Since the role of Sema3A in DM is sparse [30], our finding of a reduction in Sema3A in keratinocytes in patients of DM indicates the possible role of imbalance of NGF and Sema3A on the neuropathic skin symptoms in patients with DM. The gene discussed is NGF; the disease is dermatomyositis.